Compass Pathways secures approximately $200 million in proceeds through the exercise of outstanding warrants, strengthening its balance sheet to advance psychedelic-based mental health therapies. Compass Pathways plc , a clinical-stage biotechnology company focused on transforming mental health care through evidence-based…
Backed by the Wyss Center for Bio and Neuroengineering and leading Swiss investors, Clee Medical advances ultra-high-resolution real-time imaging to enhance precision and safety in brain surgery. The Wyss Center for Bio and Neuroengineering in Geneva has announced the successful…
SystImmune and Bristol Myers Squibb announce encouraging interim Phase III data for izalontamab brengitecan (Iza-bren) in previously treated metastatic triple-negative breast cancer (TNBC), highlighting potential improvements in patient outcomes. SystImmune, Inc. and Bristol Myers Squibb have announced positive topline results…
Kairos Pharma, Ltd. moves to expand its oncology pipeline with the proposed acquisition of two clinical-stage NSCLC assets from Celyn Therapeutics, Inc., strengthening its position in innovative cancer therapeutics. Kairos Pharma, Ltd., a clinical-stage biopharmaceutical company dedicated to advancing innovative…
The U.S. Food and Drug Administration sets a PDUFA target date of June 30, 2026, accelerating review of olezarsen for patients with severe hypertriglyceridemia. Ionis Pharmaceuticals, Inc. has announced a major regulatory milestone in its efforts to address severe hypertriglyceridemia…
IonQ Deploys One of Europe’s Most Advanced Quantum Key Distribution Networks to Strengthen Secure Communications Infrastructure IonQ , a leading quantum computing and networking company, has announced the successful deployment of the technology powering the Romanian National Quantum Communication Infrastructure…
Asahi Kasei expands into severe infectious diseases with the €780 million acquisition of AiCuris Anti-infective Cures AG, strengthening its specialty pharmaceutical pipeline and global growth strategy. Asahi Kasei has entered into a definitive agreement to acquire all issued shares of…
Royalty Pharma Names Kenneth Sun as Senior Vice President and Head of Asia, Strengthening Its Global Expansion Strategy and Regional Presence Royalty Pharma plc (Nasdaq: RPRX) today announced the appointment of Kenneth Sun as Senior Vice President and Head of…
Acadia Pharmaceuticals Reports Strong Fourth Quarter and Record Full-Year 2025 Financial Results, Highlights Pipeline Progress and Strategic Expansion Acadia Pharmaceuticals Inc today announced its financial results for the fourth quarter and full-year ended December 31, 2025, marking a milestone year…
BioTalent Canada Breaks Barriers in Opening Applications for 2026 I.D.E.A.L. Scholarship™ BioTalent Canada has opened applications for the third annual I.D.E.A.L. Scholarship which will close on June 8, 2026. Full details and application forms available on BioTalent Canada’s website.Breaking down financial…